Monopar Therapeutics Inc. · NASDAQ:MNPR
Cittadine Andrew exercised options for 5,254 Monopar Therapeutics Inc. shares (Form 4)
Traded Jun 30, 2026 · Filed Jul 2, 2026
On Jun 30, 2026, Cittadine Andrew (Chief Operating Officer) exercised options for 5,254 Monopar Therapeutics Inc. shares, leaving 55,614 shares. Filed Jul 2, 2026 (Form 4).
- Options exercised
- 5,254 shares
- Holding after
- 55,614 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Option exercise | 5,254 | 57,923 | Direct | |
| Jun 30, 2026 | Common Stock | Shares withheld for tax | 2,309 | US$92.59 | 55,614 | Direct |
Source
Related
- Monopar Therapeutics Inc.
- Cittadine Andrew
- Monopar Therapeutics Inc. shareholders
- Form 4 · Cittadine Andrew · Oct 2, 2026
- Form 4 · Cittadine Andrew · Apr 2, 2026
- Form 4 · Robinson Chandler · Oct 20, 2026
- Form 4 · Starr Christopher M · Oct 5, 2026
- Form 4 · Vu Quan Anh · Oct 2, 2026
- Form 4 · Robinson Chandler · Oct 2, 2026
- Form 4 · Robinson Chandler · Sep 28, 2026